PONI and its association with oxidative stress in type i and type II diabetes mellitus

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 5, Issue 3, 2011, Pages 126-129

  Nair, Sandhya Pillai ^a   Shah, N C ^b   Taggarsi, Anand ^c   Nayak, Uma ^c  

^a Baroda Medical College   (India)

^b GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

^c Kashiben Gordhandas Patel Children Hospital   (India)

Author keywords

Antioxidants; Diabetes; Lipid peroxidation; Paraoxonase

Indexed keywords

ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; AGED; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC PATIENT; DISEASE ASSOCIATION; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 84861337006     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2012.02.022     Document Type: Article

References (35)

1. S.T. Reddy, D.J. Wadleigh, V. Grijalva, C. Ng, S. Hama, and A. Gangopadhyay Human paraoxonase-3 is an HDL associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids Arterioscler Thromb Vasc Biol 21 2001 542 547
2. D.A. Stoltz, E.A. Ozer, T.J. Recker, M. Estin, X. Yang, and D.M. Shih A common mutation in paraoxoonase 2 results in impaired lactonase activity J Biol Chem 284 2009 35564 35571
3. A. Mazur An enzyme in animal tissues capable of hydrolyzing the phosphorous fluorine bond of alkyl fluorophosphates J Biol Chem 164 1946 271 289
4. W.N. Aldridge Serum esterase II: an enzyme hydrolyzing diethyl p nitrophenyl phosphate (E 600) and its identity with the A esterase of mammalian sera Biochem J 53 1953 117 124
5. W.N. Aldridge Serum esterase I: two types of esterase (A and B) hydrolyzing p nitrophenyl acetate, propionate and butyrate, and a method for their determination Biochem J 53 1953 110 117
6. R.C. Sorenson, S.L. Primo Parmo, C.L. Kuo, S. Adkins, O. Lockridge, and B.N. La Du Reconsideration of the catalytic centre and mechanism of mammalian paraoxonase/arylesterase Proc Natl Acad Sci 92 1995 7187 7191
7. M.I. Mackness, B.M. Mackness, and P.N. Durrington Paraoxonase and coronary heart disease Atheroscler Suppl 3 4 2002 49 55
8. B. Mackness, P.N. Durrington, A.J.M. Boulton, D. Hine, and M.I. Mackness Serum paraoxonase activity in patients with type I diabetes compared to healthy controls Eur J Clin Invest 32 2002 259 264
9. S.S. Kilie, S. Aydin, N. Kilic, F. Erman, S. Aydin, and I. Celik Serum arylesterase and paraoxonase activity in patients with chronic hepatitis World J Gastroenterol 11 46 2005 7351 7354
10. M. Parakash, N.M. Phani, R. Kavya, and M. Supriya Paraoxonase: its antiatherogenic role in chronic renal failure Indian J Nephrol 20 1 2010 9 12
11. G. Paragh, P. Balla, E. Katone, I. Seres, A. Egerhazi, and I. Degrel Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia Eur Arch Psychiatry Clin Neurosci 252 2002 63 67
12. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes 1995-2025; prevalence, numerical estimates, and projection Diabetes Care 21 1998 1414 1431
13. A. Ramachandran, C. Snehalatha, A. Kapur, V. Vijay, and V. Mohan High prevalence of diabetes and impaired glucose tolerance in India. National Urban Diabetes Survey Diabetologia 44 2001 1094 1101
14. L.A. Trivelli, H.M. Raney, and H.T. Lai Hemoglobin components in patients with diabetes mellitus New Engl J Med 284 1971 353 357
15. S. Marklund, and G. Marklud A simple assay for super oxide dismutase using autooxidation of pyrogallol Eur J Biochem 47 1974 469 472
16. K.M. Wilbur, Mernhein, and O.W. Shapior The thiobarbituric acid method for malondialdhyde estimation Arch Biochem Biophys 250 1943 305 313
17. W. Phuntuwate, C. Suthisisang, B. Koanantakul, M.I. Mackness, and B. Mackness Measurement of PON 1: PON 1 status in Thai population J Hum Genet 50 2005 293 300
18. C.E. Furlong, R.J. Richter, S.L. Siedel, L.G. Costa, and A.G. Motulsky Spectrophotometric assays for the enzymatic hydrolysis of the active metabolite of chlorpyrifos and parathion by plasma paraxonase/arylesterase Anal Biochem 180 1989 242 247
19. G. Paragh, I. Seres, Z. Balogh, Z. Varga, I. Kárpáti, and J. Mátyus The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia Nephron 80 1998 166 170
20. E. Beutler, O. Duran, and B.M. Kelley Improved method for the determination of blood glutathione J Lab Clin Med 61 1963 882 888
21. T. Sakurai, and S. Tsuchiya Superoxide production from nonenzymatically glycated protein FEBS Lett 236 1988 406 410
22. A.C. Maritim, R.A. Sanders, and J.B. Watkins Diabetes, oxidative stress, and antioxidants: a review J Biochem Mol Toxicol 17 2003 24 38
23. A. Ceriello A hyperglycemia: the bridge between non enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications Diabetes Nutr Metab 12 1 1999 42 46
24. S. Shinde, V. Dhadke, and A. Suryakar Evaluation of oxidative stress in type 2 diabetes mellitus and follow up along with vitamin E supplementation Ind J Clin Biochem 26 1 2011 74 77
25. R. Nobar, and R. Pour Total antioxidant capacity, superoxide dismutase and glutathione peroxidase in diabetic patients Med J Islam Acad Sci 12 4 1999 104 114
26. W.T. Hsu, L.Y. Tsai, S.K. Lin, J.K. Hsiao, and B.H. Chen Effects of diabetes duration and glycemic control on free radicals in children with type 1 diabetes mellitus Ann Clin Lab Sci 36 2006 174 178
27. D. Giuliano, A. Ceriello, and G. Paolisso Oxidative stress and diabetic vascular complications lead to tissue damage through common pathway Diabetes Care 19 1996 257 267
28. Y. Dincer, T. Akcay, A. Zeynep, and H. Ilkova Effect of oxidative stress on glutathione pathway in red blood cells from patients with IDDM Metabolism 51 2002 1360
29. J. Aaseth, and G. Stoa-Birketvedt Glutathione in overweight patients with poorly controlled type 2 DM J Trace Elem Exp Med 13 2000 105
30. P.J. Thornalley, A.C. McLellan, T.W. Lo, J. Benn, and P.H. Sonksen Negative association between erythrocyte reduced glutathione concentration and diabets mellitus complication Clin Sci 91 1996 575
31. R.S. Gaskin, D. Estwick, and R. Peddi G6PD deficiency: its role in the high prevalence of diabetes mellitus Ethn Dis 11 2001 749
32. D.N. Nevin, A. Zambon, and C.E. Furlong Paraoxonase genotype, lipoprotein lipase activity and HDL Arterioscler Thromb Vasc Biol 16 1996 1243 1249
33. C.A. Abbott, M.I. Mackness, S. Kumar, A.J. Boulton, and P.N. Durrington Serum paraoxonase activity, concentration and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins Arterioscler Thromb Vasc Biol 15 1995 1812 1818
34. M. Tomas, G. Latorre, M. Senti, and J. Marrugat The antioxidant function of high density lipoproteins: a new paradigm in atherosclerosis Rev Esp Cardiol 57 2004 557 569
35. O.B. Ekmekci, O. Donma, H. Ekmekci, N. Yildirim, O. Uysal, and E. Sardogan Plasma paraoxonase activities, lipoprotein oxidation, and trace element interaction in asthmatic patients Biol Trace Elem Res 111 1 2006 41 52